Sun Pharma Advanced Research Company Limited (SPARC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.336x

Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) has a cash flow conversion efficiency ratio of 0.336x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.16 Billion ≈ $-12.53 Million USD) by net assets (Rs-3.45 Billion ≈ $-37.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sun Pharma Advanced Research Company Lim (SPARC) liquidity interval to measure how many days the company can operate on defensive assets alone.

Sun Pharma Advanced Research Company Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sun Pharma Advanced Research Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sun Pharma Advanced Research Company Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Artis Real Estate Investment Trust
TO:AX-UN
0.040x
Summit
TA:SMT
0.016x
Yueyang Forest & Paper Co Ltd
SHG:600963
-0.032x
Warom Technology Inc Co
SHG:603855
-0.016x
Treasure ASA
OL:TRE
0.012x
Nesco Limited
NSE:NESCO
0.077x
Guangdong Guanhao High-Tech Co Ltd
SHG:600433
-0.001x
Coronation Fund Managers Ltd
JSE:CML
0.492x

Annual Cash Flow Conversion Efficiency for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sun Pharma Advanced Research Company Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Sun Pharma Advanced Research Company Lim market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs-2.17 Billion
≈ $-23.46 Million
Rs-3.60 Billion
≈ $-38.96 Million
1.661x +148.66%
2024-03-31 Rs1.26 Billion
≈ $13.60 Million
Rs-4.29 Billion
≈ $-46.42 Million
-3.413x -2431.86%
2023-03-31 Rs5.13 Billion
≈ $55.45 Million
Rs-691.20 Million
≈ $-7.48 Million
-0.135x +97.98%
2022-03-31 Rs312.26 Million
≈ $3.38 Million
Rs-2.08 Billion
≈ $-22.52 Million
-6.669x -838.67%
2021-03-31 Rs-1.68 Billion
≈ $-18.20 Million
Rs-1.52 Billion
≈ $-16.43 Million
0.903x -92.02%
2020-03-31 Rs-186.38 Million
≈ $-2.02 Million
Rs-2.11 Billion
≈ $-22.80 Million
11.310x +2048.94%
2019-03-31 Rs2.96 Billion
≈ $32.04 Million
Rs-1.72 Billion
≈ $-18.59 Million
-0.580x +41.35%
2018-03-31 Rs1.85 Billion
≈ $19.98 Million
Rs-1.83 Billion
≈ $-19.77 Million
-0.989x -23.37%
2017-03-31 Rs1.60 Billion
≈ $17.27 Million
Rs-1.28 Billion
≈ $-13.85 Million
-0.802x +45.76%
2016-03-31 Rs299.03 Million
≈ $3.23 Million
Rs-442.12 Million
≈ $-4.78 Million
-1.479x -272.84%
2015-03-31 Rs997.99 Million
≈ $10.79 Million
Rs-395.76 Million
≈ $-4.28 Million
-0.397x -249.72%
2014-03-31 Rs1.39 Billion
≈ $15.06 Million
Rs368.95 Million
≈ $3.99 Million
0.265x +130.12%
2013-03-31 Rs1.08 Billion
≈ $11.73 Million
Rs-953.44 Million
≈ $-10.31 Million
-0.879x -184.34%
2012-03-31 Rs-666.09 Million
≈ $-7.20 Million
Rs-694.49 Million
≈ $-7.51 Million
1.043x +134.07%
2011-03-31 Rs56.23 Million
≈ $608.16K
Rs25.05 Million
≈ $270.90K
0.445x -50.20%
2010-03-31 Rs141.24 Million
≈ $1.53 Million
Rs126.34 Million
≈ $1.37 Million
0.895x +25.38%
2009-03-31 Rs356.78 Million
≈ $3.86 Million
Rs254.54 Million
≈ $2.75 Million
0.713x +256.80%
2008-03-31 Rs448.18 Million
≈ $4.85 Million
Rs-203.92 Million
≈ $-2.21 Million
-0.455x -54787.50%
2007-03-31 Rs497.01 Million
≈ $5.37 Million
Rs-412.00K
≈ $-4.46K
-0.001x --

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic
Market Cap
$850.97 Million
Rs78.69 Billion INR
Market Cap Rank
#9786 Global
#483 in India
Share Price
Rs242.47
Change (1 day)
+1.19%
52-Week Range
Rs108.71 - Rs242.47
All Time High
Rs519.35
About

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia th… Read more